EFFICACY AND SAFETY OF AK002 IN ADULT PATIENTS WITH ACTIVE EOSINOPHILIC GASTRITIS AND/OR EOSINOPHILIC GASTROENTERITIS: PRIMARY RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL (ENIGMA STUDY)

AK002 - Allakos

https://www.professionalabstracts.com/ueg2019/Iplanner/#/presentation/4090

Dellon E.1; Peterson K.2; Murray J.3; Falk G.4; Gonsalves N.5; Chehade M.6; Leung J.7; Genta R.8; Rothenberg M.9; Khoury P.10; Bledsoe A.3; Shaw C.11; Rasmussen H.11; Singh B.11; Chang A.11; Kamboj A.11; Hirano I.12

Oct 4, 2019